RxDoctor Payments Data

Lindsi Pizzolato, NP

Family · Lafayette, LANPI 1720427966

Payments from drug & device makers

$597in general payments, 2019–2025

Across 30 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$292
  • Janssen Products, LP$87
  • Insmed, Inc.$68
  • AbbVie$44
  • Viiv Healthcare Company$35
  • Philips North America LLC$19
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$46177%
  • Education$13623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$597 in reported general payments places this provider in the 50th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$145,737
Medicare patients
447
Services billed
1,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpclusaSofosbuvir/Velpatasvir15$358,001
Daptomycin87$128,796
TeflaroCeftaroline Fosamil Acetate27$64,163
TivicayDolutegravir Sodium14$31,104
ErtapenemErtapenem Sodium36$18,703
Vancomycin Hcl51$14,532
Meropenem24$7,708
Cefepime Hcl50$5,739
Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod25$5,299
CeftriaxoneCeftriaxone Sodium26$5,256
Cefazolin Sodium33$1,544
Ciprofloxacin-D5wCiprofloxacin In 5 % Dextrose15$1,303
Sodium Chloride0.9 % Sodium Chloride99$932
Doxycycline Hyclate12$308
Cefadroxil11$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadEpclusa$16$358,00115 claims
AbbVieTeflaro$44$64,16327 claims
Viiv Healthcare CompanyTivicay$35$31,10414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,610 family providers in Louisiana.

Other family in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →